Writers |
METTL3 |
Oncogene |
Promote cell proliferation and growth |
HBXIP/let-7g/METTL3/HBXIP |
[60] |
Promote proliferation and migration |
|
[62] |
Promote cell proliferation, tumor growth; Inhibit cell apoptosis |
Bcl-2 |
[61] |
METTL14 |
Oncogene |
Promote proliferation and migration |
|
[62] |
Promote cell migration and invasion |
Has-miR-146a-5p |
[76] |
Promote cell proliferation and colony formation and inhibit cell apoptosis |
LNC942-METTL14-CXCR4/CYP1B1 |
[71] |
Tumor suppressor |
Suppress cell viability, colony formation and migratory abilities |
|
[64] |
KIAA1429 |
Oncogene |
Promote proliferation and migration |
CDK1 |
[65] |
Hakai |
Tumor suppressor |
Suppress cell proliferation and migration |
ERα |
[79] |
Erasers |
FTO |
Oncogene |
Promote cell proliferation, colony formation and metastasis |
BNIP3 |
[67] |
ALKBH5 |
Oncogene |
Promote cell viability, colony formation and migratory abilities |
|
[64] |
Increase the percentage of breast cancer stem cells |
NANOG |
[82] |
Promote metastasis from breast to lungs |
NANOG and KLF4 |
[83] |
Tumor suppressor |
Suppress proliferation and migration |
|
[76] |
Readers |
YTHDF3 |
Oncogene |
Independent prognostic factor for overall survival |
|
[25] |
hnRNPC |
Oncogene |
Promote cell proliferation and tumor growth |
dsRNA-induced interferon response |
[72] |
hnRNPA2/B1 |
Oncogene |
Promote cell proliferation, decrease apoptosis, and prolong the S phase of the cell cycle |
STAT3 and ERK1/2 signaling pathway |
[73] |
Tumor suppressor |
Suppress EMT and metastasis |
PFN2 |
[86] |
IGF2BP |
Oncogene |
Promote stemness of breast cancer cells |
Myc |
[84] |
eIF3m |
Oncogene |
Promote the cell proliferation, migration, invasion as well as suppress apoptosis in TNBC |
|
[71] |
eIF3g |
Oncogene |
Promote lymph node metastasis |
hnRNPU, HSZFP36 and β-actin |
[87] |